A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Alliance for Clinical Trials in Oncology
Radiation Therapy Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Alliance for Clinical Trials in Oncology
St. Jude Children's Research Hospital
SWOG Cancer Research Network
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Texas Southwestern Medical Center
Northwestern University
M.D. Anderson Cancer Center
Children's Hospital of Philadelphia
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
St. Jude Children's Research Hospital
Dana-Farber Cancer Institute
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Massachusetts General Hospital
Trans Tasman Radiation Oncology Group
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Affiliated Hospital to Academy of Military Medical Sciences
Roswell Park Cancer Institute
City of Hope Medical Center
Hoffmann-La Roche
Children's Oncology Group
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
Northside Hospital, Inc.
Centre Henri Becquerel
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Barbara Ann Karmanos Cancer Institute
University Hospital, Limoges